Alstroem syndrome gene, gene variants, expressed protein and methods of diagnosis for Alstroem syndrome
OwnerGayle B. Collin, Jan Marshall +4inventors
InventorsGayle B. Collin, Jan Marshall, Mitchell L. Martin, Juergen K. Naggert, Patsy M. Nishina, W. Venus So
Life of this patent
Estimating the term…
Abstract
The present invention relates to a nucleic acid sequence linked to Alström syndrome, variants of that nucleic acid sequence, the protein produced by that nucleic acid sequence and screening methods for testing individuals to determine if they are carriers of Alström syndrome.
Claims18
An isolated nucleic acid molecule selected from the group consisting of:
- nucleotide sequence SEQ ID NO:NO:
- 1,
- nucleotide sequences hybridizing to SEQ ID NO:NO:
- 1 or the complement of SEQ ID NO:NO:
- 1 under stringent hybridization conditions and
- nucleotide sequences encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:NO:
- 2.
An isolated host cell comprising a nucleic acid molecule selected from the group consisting of
- nucleotide sequence SEQ ID NO:
- 1,
- nucleotide sequences hybridizing to SEQ ID NO:
- 1 or the complement of SEQ ID NO:
- 1 under stringent hybridization conditions and
- nucleotide sequences encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:
- 2.
An isolated polypeptide comprising an amino acid sequence selected from the group consisting of
- the amino acid sequence of SEQ ID NO:
- 2,
- the amino acid sequence encoded by the nucleic acid molecule having the nucleotide sequence SEQ ID NO:
- 1,
- the amino acid sequence encoded by the nucleic acid molecule having nucleotide sequences hybridizing to SEQ ID NO:
- 1 or the complement of SEQ ID NO:
- 1 under stringent hybridization conditions and
- the amino acid sequence encoded by the nucleic acid molecule having nucleotide sequences encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:
- 2.
An isolated polypeptide comprising at least 50 contiguous amino acid residues of the amino acid sequence of SEQ ID NO:
- 2.
An isolated polypeptide comprising at least 100 contiguous amino acid residues of the amino acid sequence of SEQ ID NO:
- 2.
An isolated polypeptide comprising at least 200 contiguous amino acid residues of the amino acid sequence of SEQ ID NO:
- 2.
A method of diagnosing Alström Syndrome or screening for carriers of Alström Syndrome comprising testing genetic material from a putative carrier for mutations in SEQ ID NO:
- 1 of ALMS1.
A method of diagnosing Alström Syndrome in a patient, the method comprising determining the presence or absence of the protein encoded by SEQ ID NO:
- 1 in a tissue sample of the patient.
A method for identifying a compound suitable for treating Alström Syndrome comprising:
- contacting a polypeptide having the amino acid sequence of SEQ ID NO:
- 2 or a fragment thereof, or a cell expressing a polypeptide having the amino acid sequence of SED ID NO:
- 2 or a fragment thereof, with a test compound;
- and
- determining whether said polypeptide or fragment thereof binds to said test compound, thereby identifying a compound suitable for treating Alström Syndrome.
Dependencies are inferred from the claim text.